D59.4

Clinical Causes: Mechanical trauma to red blood cells, often caused by artificial heart valves or certain medical devices. Microangiopathic processes where small blood vessels cause damage to passing red blood cells, seen in conditions like thrombotic thrombocytopenic purpura (TTP) or hemolytic uremic syndrome (HUS). Exposure to toxic substances or chemicals that damage red blood cell membranes, such as certain drugs, insecticides, or snake venoms.

Key Symptoms: Fatigue and weakness due to reduced oxygen transport. Pale skin and mucous membranes (pallor). Dark-colored urine caused by the presence of hemoglobin. Shortness of breath or rapid breathing. Jaundice (yellowing of the skin and eyes) as a result of increased bilirubin levels. Enlarged spleen or liver in some cases. Possible episodes of limb pain or discomfort during hemolytic crises.

Diagnosis Path: Additional tests such as lactate dehydrogenase (LDH), haptoglobin levels, bilirubin, and specific tests for toxins or mechanical causes may be performed.

Treatment Protocols: Removing or addressing the source of mechanical damage, such as replacing or repairing faulty medical devices. Managing complications related to microangiopathic processes with medications like plasma exchange or therapies targeting underlying conditions. Avoiding exposure to toxic substances and providing supportive care, including blood transfusions if necessary. Treating associated conditions such as infections or clotting disorders that may trigger hemolysis. Monitoring and managing symptoms to prevent complications like anemia or organ damage.